Combination therapy using laser photothermal interaction and immunological stimulation has demonstrated
its ability to induce immunological responses. Glycated chitosan (GC), an immunological stimulant, and
imiquimod, a new type of immune response modifier (IRM), when used in conjunction with laser
phototherapy, have shown to have a great immunological stimulation function. Specifically, imiquimod can
help release cytokines from immunocompetent cells, stimulate TH1 lymphocyte responses (CD8+ T-cells),
and recruit additional dendritic cells. To study the effects of immunoadjuvnats in combination of laser
photo-irradiation, we treated animal tumors with laser-ICG-GC combination and late-stage melanoma
patients with laser-ICG-imiquimod combination. At designated times, tumors, blood, and spleens in both
treated and untreated animals were colleted for analysis. The major immunological indicators, such as IL-6,
IL-12, IFN-gamma, CD4, and CD8 were analyzed. The same immunological analysis was also performed
for melanoma patients treated by the laser-imiquimod combination.
|